Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight? - Wikidata - awgldk - TriplyDB

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

http://www.wikidata.org/entity/Q38759270

about

Alginate Oligosaccharide DP5 Exhibits Antitumor Effects in Osteosarcoma Patients following Surgery.Novel molecular insights and new therapeutic strategies in osteosarcoma

P2860

Q41684488-169CEF9D-44EA-420D-9AC8-1C15F6DB277C Q57814118-4315E4AC-FBA7-48CA-9768-E8FE577FEA14

P2860

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

http://www.wikidata.org/entity/Q38759270

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

@en

type

label

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

@en

prefLabel

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

@en

P1433

Q38759270-162E3D56-015F-439A-AA2A-B4D9803F799C

P1476

Q38759270-63AE9755-8660-45AC-B271-98A860D7DE93

P2093

Q38759270-55ABF63F-B48B-4CFC-8379-81B63E7622D6

Q38759270-6FE27327-50FE-49B7-850C-86A707A4236E

Q38759270-768F0D30-2BFB-4AD4-8583-B3AE529F0F6B

Q38759270-B98EDA86-CE24-47EC-BD4A-CC9A73E3A8D6

Q38759270-EF11FD27-4A5C-4A72-B4DE-6BD372CBE2BA

P2860

Q38759270-1066B055-DFF7-4D88-BE10-922EC1ED546D

Q38759270-13728D2C-0CB7-40E6-BC78-A0DEE41DFA8C

Q38759270-1886F480-5E67-4D03-8D85-63C19795DF2C

Q38759270-1C939479-AE95-4453-BE5E-1CC489B92AFB

Q38759270-2119B3CF-D921-4B07-BDA3-630A65890AF0

Q38759270-22D6B63F-5B42-44CB-BF74-0C5510A5D359

Q38759270-2486AE9F-0644-4956-AA03-C9031A1DA208

Q38759270-4228ACD4-6B6D-4BCB-9828-1677AAB9863E

Q38759270-5E3A862B-FE10-420F-8EC0-D8347F2087CC

Q38759270-5FF3D544-CD13-4539-806F-C2C379D91346

P304

Q38759270-7D48E11D-EA8C-43AB-A987-4D273723AF2E

P31

Q38759270-01950467-CB12-42C1-B9A7-34DA572064AB

P356

Q38759270-3DFF1177-C3F7-42D2-8846-41FC22B6E84B

P407

Q38759270-2D6A64F7-C486-4A26-A1C7-6A76902D3793

P433

Q38759270-6D855210-F052-4BC3-A729-01A5AB78AC08

P478

Q38759270-394625CD-D62D-4E60-9C64-22DCE5090535

P50

Q38759270-005464F0-D318-485E-A553-4B0C6D58B6E7

Q38759270-C00DBB2F-B9D3-45F7-92DE-7710818222D2

P577

Q38759270-66FD81EF-BFF3-4597-A443-F711892128A3

P698

Q38759270-3ECC486C-54EF-41F3-AE57-A09403451450

P356

P1433

Future Oncology

P1476

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

@en

P2093

Chiara Riganti

http://www.w3.org/2001/XMLSchema#string

Elisa Tavanti

http://www.w3.org/2001/XMLSchema#string

Marilù Fanelli

http://www.w3.org/2001/XMLSchema#string

Piero Picci

http://www.w3.org/2001/XMLSchema#string

Serena Vella

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetic study of aldoxorubicin in patients with solid tumors

Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.

DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials.

A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma.

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma.

An injectable nanoparticle generator enhances delivery of cancer therapeutics.

A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity.

ABC transporters as potential targets for modulation of drug resistance.

Emerging drugs for high-grade osteosarcoma.

Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?

P304

673-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0519

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Maria Hattinger

P577

2017-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28183198

http://www.w3.org/2001/XMLSchema#string